LRRK2 and Parkinson disease: The identification of this pathway for LRRK2-dependent suppression of the degradative activity of lysosomes opens up opportunities to define more detailed molecular mechanisms and to determine the contributions of such regulation to both normal cell biology and to Parkinson’s disease risk.